AI assistant
Neuland Laboratories Limited. Earnings Release 2021
62255_rns_2021-05-08_598f22f9-5cc9-45b2-8772-a3d0c7faf543.pdf
Earnings Release
Open in viewerOpens in your device viewer
May 8, 2021
To BSE Limited Phiroze Jeejeebhoy Towers, 25th Floor, Dalal Street, Mumbai – 400 001
To The National Stock Exchange of India Ltd Exchange Plaza, Bandra Kurla Complex, Bandra (E) Mumbai – 400 001
Scrip Code: 524558
Scrip Code: NEULANDLAB; Series: EQ
Dear Sirs,
Results Release and Earnings Call Notice
We refer to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements), 2015 and enclose a copy of the Q4 FY 2020-2021 Earnings Call details, for your information and records.
Thanking you,
Yours faithfully,
For Neuland Laboratories Limited
Sarada Bhamidipati
Digitally signed by Sarada Bhamidipati DN: cn=Sarada Bhamidipati, o=Neuland Laboratories Limited, ou, email=[email protected], c=IN
Date: 2021.05.08 12:14:04 +05'30'
Sarada Bhamidipati Company Secretary
Encl: As above
Neuland Laboratories Limited's Q4FY21 Results Conference Call At 17:00 hrs. IST on May 11, 2021
Neuland Laboratories Limited will announce its results for the fourth quarter and financial year ended March 31, 2021 on May 11, 2021. The results will also be made available on the website of the Company, www.neulandlabs.com
Following the announcement, the management of the Company will host an Earnings Call on
May 11, 2021 at 17:00 hrs. The details of the earnings call are:
International Toll-Free Number: USA – 18667462133 | UK – 08081011573 | Singapore – 8001012045 | Hong Kong – 800964448
About Neuland Laboratories Limited (BSE:524558, NSE: NEULANDLAB)
For over 37 years, Neuland Labs has been at the forefront of manufacturing APIs through its cGMP manufacturing facilities, working with customers in close to 80 countries. Neuland Labs has developed more than 300 processes and 75 APIs and has filed over 898+ Regulatory filings in the US (57 active US DMFs), the European Union (EU) and other geographies. Its manufacturing facilities are inspected and approved by the U.S. FDA and other leading regulatory agencies. Its record of quality manufacturing and reliability is highlighted by cGMP certifications that include the U.S. FDA, TGA (Australia), EDQM (EU), German Health Authority, ANVISA (Brazil), EMA (EU), Cofepris (Mexico), KFDA (Korea), PMDA (Japan), CFDA (China), FSI "SID &GP" Russia, Health Canada, ISO 9001, ISO14001, OHSAS18001 and ISO 27001.
For more information, visit www.NeulandLabs.com.
For more queries please contact: